BRCA: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
Jaime Prilusky (talk | contribs)
m BRCA1 moved to BRCA: requested by Editor
Michal Harel (talk | contribs)
No edit summary
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
<StructureSection load='' size='450' side='right' caption='Human BRCA1 BRCT1 and BRCT2 domains complex with phosphopeptide (PDB code [[3coj]]) ' scene='75/750267/Cv/3' pspeed='8'>
<StructureSection load='' size='450' side='right' caption='Human BRCA1 BRCT1 and BRCT2 domains complex with phosphopeptide (PDB code [[3coj]]) ' scene='75/750267/Cv/4' pspeed='8'>


== Function ==
== Function ==
Line 11: Line 11:


== Structural highlights ==
== Structural highlights ==
The <scene name='75/750267/Cv/1'>phosphopeptide binds at the interface between the BRCT1 and BRCT2 domains</scene>.  These domains contain most of the mutations seen in BRCA1<ref>PMID:18452305</ref>. <scene name='75/750267/Cv/2'>Phosphoserine binding</scene>.  
The <scene name='75/750267/Cv/5'>phosphopeptide binds at the interface between the BRCT1 and BRCT2 domains</scene>.  These domains contain most of the mutations seen in BRCA1<ref>PMID:18452305</ref>. <scene name='75/750267/Cv/6'>Phosphoserine binding</scene>.  
 
</StructureSection>


==3D structures of BRCA==
==3D structures of BRCA==
[[BRCA 3D structures]]


Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
</StructureSection>
{{#tree:id=OrganizedByTopic|openlevels=0|
 
*BRCA1
 
**[[4ofb]], [[4y18]], [[4y2g]], [[4u4a]], [[4jlu]], [[4ifi]], [[4igk]], [[3k0h]], [[3k0k]], [[3coj]], [[1y98]], [[1t15]], [[1t29]], [[1t2v]] - hBRCA1 BRCT1 domain + peptide inhibitor - human<br />
**[[3pxa]], [[3pxb]], [[3pxc]], [[3pxd]], [[3pxe]], [[3k15]], [[3k16]] - hBRCA1 BRCT1 domain (mutant) + peptide inhibitor<br />
**[[1jnx]] - hBRCA1 BRCT domain<br />
**[[2ing]], [[1t2u]], [[1n5o]] - hBRCA1 BRCT1 domain (mutant)<br />
**[[1oqa]] - hBRCA1 BRCT-C domain - NMR<br />
**[[1l0b]] - BRCA1 BRCT domain - rat<br />
**[[2n9e]] - hBRCA1 SUMO-interacting motif + small ubiquitin-related modifier - NMR<br />
**[[4mkf]], [[4mkg]] - hBRCA1 SUMO-interacting motif - NMR<br />
**[[1jm7]] - hBRCA1 Ring domain + BARD1 ring domian - NMR<br />
 
*BRCA2


**[[1iyj]], [[1miu]] – hBRCA2 residues 2335-3151 + DSS1<br />
**[[1mje]] – hBRCA2 residues 2335-3151 + DSS1 + ssDNA<br />
**[[1n0w]] – hBRCA2 BRC repeat 4 + RAD51 + linker<br />
}}
== References ==
== References ==
<references/>
<references/>
[[Category:Topic Page]]
[[Category:Topic Page]]

Latest revision as of 12:58, 16 April 2019


Function

BRCA1 and BRCA2 or breast cancer type 1 susceptibility protein are tumor suppressors which help repair damaged DNA. For more details see:

Disease

Mutations in BRAC1 and BRAC2 are associated with increased risk of breast cancer, ovarian cancer and to a lesser extent with other cancers[1].

Structural highlights

The . These domains contain most of the mutations seen in BRCA1[2]. .

3D structures of BRCA

BRCA 3D structures


Human BRCA1 BRCT1 and BRCT2 domains complex with phosphopeptide (PDB code 3coj)

Drag the structure with the mouse to rotate

ReferencesReferences

  1. Petrucelli N, Daly MB, Pal T. BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer PMID:20301425
  2. Shen Y, Tong L. Structural evidence for direct interactions between the BRCT domains of human BRCA1 and a phospho-peptide from human ACC1. Biochemistry. 2008 May 27;47(21):5767-73. Epub 2008 May 2. PMID:18452305 doi:10.1021/bi800314m

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Joel L. Sussman, Jaime Prilusky